In an article, author is Steinhoff, B. J., once mentioned the application of 3878-55-5, Name is 4-Methoxy-4-oxobutanoic acid, molecular formula is C5H8O4, molecular weight is 132.12, MDL number is MFCD00002788, category is benzisoxazole. Now introduce a scientific discovery about this category, Recommanded Product: 3878-55-5.
Zonisamide (ZNS) is a benzisoxazole derivate not structurally related to currently licensed antiepileptic drugs. It has multiple modes of action whose impact on the anticonvulsant effect is not yet fully understood: ZNS interrupts the synchronized neuronal firing through direct effects on voltage-dependent sodium and T-type calcium channels. Thus epileptiform propagation and activity are blocked. Furthermore ZNS has a modulating effect on the GABAergic inhibition, and may act on the dopaminergic and serotonergic neurotransmission and on acetylcholine pathways. An inhibition of excitatory glutamatergic transmission by reduction of the presynaptic release of glutamate has been also described. These modes of action suggest a broad anticonvulsant efficacy.
Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 3878-55-5, Recommanded Product: 3878-55-5.
Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics